Disialoganglioside GD3 Antibody (ecromeximab-MMAE) [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28521DL594
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry, Functional
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Recombinant Monoclonal Human IgG1 Clone # ecromeximab-MMAE
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
GD3
Clonality
Monoclonal
Host
Human
Isotype
IgG1
Applications for Disialoganglioside GD3 Antibody (ecromeximab-MMAE) [DyLight 594]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Disialoganglioside GD3
Alternate Names
3g11
Additional Disialoganglioside GD3 Products
Product Documents for Disialoganglioside GD3 Antibody (ecromeximab-MMAE) [DyLight 594]
Product Specific Notices for Disialoganglioside GD3 Antibody (ecromeximab-MMAE) [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...